Suryanarayana Prakash Goutham, Copeland Hannah, Friedman Mark, Copeland Jack G
Department of Cardiology Sarver Heart Center, University of Arizona Medical Center, Tucson, Arizona.
Clin Cardiol. 2014 Jun;37(6):331-6. doi: 10.1002/clc.22275. Epub 2014 Apr 1.
In view of limited data on the subject of graft and patient survival differences between African American (AA) and non-AA heart transplant recipients, we reviewed our experience.
There is a higher mortality among AA recipients compared with non-AA recipients after cardiac transplantation.
The study included all AA patients who have received a heart transplant in our center since 1983. Stepwise Cox regression was used for covariates affecting the survival. The χ(2) test was employed to identify the effects of a mechanical assist device and pretransplant creatinine (Cr) on the outcomes in AA and non-AA patients. Kaplan-Meier curves were used to examine survival.
The average survival among AA recipients was 5.4 years, compared with 12 years for the non-AA recipients, with 1-, 5-, and 10-year survival rates of 80%, 55%, and 25%, respectively. This was found to be statistically inferior to the survival probabilities of 92%, 78%, and 58% for the non-AA group (P < 0.005). Based on stepwise Cox regression, the variables such as ethnicity (P < 0.05), pretransplant Cr (P < 0.05), presence of a mechanical assist device (P < 0.005), and United Network for Organ Sharing (UNOS) status at transplant (P < 0.05) independently predicted the outcomes. Kaplan-Meier analysis of pretransplant Cr level and survival showed that the AA group did significantly worse for all Cr classes.
There is a statistically significant difference in outcomes between AA and non-AA patients after cardiac transplantation. African American patients have decreased survival over a period of time. Pretransplant Cr, ethnicity, presence of a mechanical assist device, and UNOS status at transplantation are independent predictors of outcomes.
鉴于非裔美国人(AA)和非非裔美国人心脏移植受者之间移植物和患者生存差异这一主题的数据有限,我们回顾了我们的经验。
心脏移植后,AA受者的死亡率高于非AA受者。
该研究纳入了自1983年以来在我们中心接受心脏移植的所有AA患者。采用逐步Cox回归分析影响生存的协变量。采用χ²检验确定机械辅助装置和移植前肌酐(Cr)对AA和非AA患者结局的影响。采用Kaplan-Meier曲线分析生存情况。
AA受者的平均生存期为5.4年,而非AA受者为12年,1年、5年和10年生存率分别为80%、55%和25%。结果发现,这在统计学上低于非AA组92%、78%和58%的生存概率(P<0.005)。基于逐步Cox回归分析,种族(P<0.05)、移植前Cr(P<0.05)、机械辅助装置的使用(P<0.005)以及移植时器官共享联合网络(UNOS)状态(P<0.05)等变量可独立预测结局。对移植前Cr水平和生存情况的Kaplan-Meier分析表明,所有Cr分级的AA组情况均明显较差。
心脏移植后,AA和非AA患者的结局存在统计学显著差异。非裔美国人患者在一段时间内生存率降低。移植前Cr、种族、机械辅助装置的使用以及移植时的UNOS状态是结局的独立预测因素。